• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Here's 2 Very Lucrative Trades From My New Trading Venture

When stock fundamentals and stock valuations diverge, profit opportunities are created.
By JIM COLLINS
Jul 18, 2019 | 03:26 PM EDT
Stocks quotes in this article: ILMN, NFLX, SPY, TSLA, NOW, ISRG, WDAY, SQ, PLD, HNHPF

The system works! Every degenerate gambler in Las Vegas believes that mantra, and I am starting to believe it myself. The model I have developed for my new trading venture, Excelsior Capital Partners, has already produced two very lucrative trades. I mentioned nine stocks that my model had identified as being massively overvalued (see below for the full list) in my Real Money column last Thursday. Two hours after that column posted, Illumna (ILMN) surprised the Street with a truly nasty profit warning, and last night's admission of a shocking lack of subscriber growth in the second quarter has tanked Netflix (NFLX) shares today.

So far so good, and I will continue to build short positions, usually via buying put options, in the other names on my hit list. While my valuation methodology will remain proprietary to Excelsior, I am not giving anything away by noting that it is based on publicly available financial data and estimates. So, why aren't other fund managers doing these trades? Well, some are, of course, and the bidding up of implied volatility in options contracts before earnings reports (this is especially apparent in Netflix's option chain) turned my trades in ILMN and NFLX from great to merely very good.

The profits are there for the taking, though, and that leads to the key issue facing the U.S stock market and its valuation. Sometimes it seems as if nobody is actually trying to value it. It is just go-go-go and let's all dance to the tune of our Pied Piper, Federal Reserve Chair Jerome Powell. That works until it doesn't work, and when it does work, it is most effective via broad market ETFs like (SPY) .

As CNBC's Bob Pisani likes to note, though, it's a market of stocks, not a stock market. Some semblance of sanity seems to be returning to the market with this week's pullback, but we are still very near all-time highs for the three major U.S. indices. In its rush to push stock prices to the stratosphere, the market has priced in growth rates that just are not attainable. That's where the idiosyncratic factors driving individual stock valuations come into play, and that's what has pushed Excelsior out of the gates with big gains.

So, the market that is go-go-go has really been laser-focused on growth-growth-growth without the proper due diligence being applied to the companies that need to produce that growth. Illumina's revised revenue guidance notes sales in the second quarter of $835 million versus $830 million in the second quarter of 2018. That's a 0.6% growth rate. But ILMN, was - and still is - valued by the markets as a "growth stock" in the "growth industry" of genetic sequencing.

The market also missed a deterioration in Netflix's fundamentals. The 2.7 million net subscribers Netflix added in the second quarter compute to a 1.8% sequential growth rate. But NFLX is a growth stock, or so the bulls would tell you.

While Excelsior is in its infancy, my Wall Street career spans more than 27 years. I have learned a thing or two. The genesis of my system is my fervent belief that when stock fundamentals and stock valuations diverge, profit opportunities are created. It's working so far.

Tesla (TSLA)

ServiceNow (NOW)

Illumina ILMN

Intuitive Surgical (ISRG)

Workday (WDAY)

Netflix NFLX

Square (SQ)

Prologis (PLD)

Hon Hai (HNHPF)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Jim Collins had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading

More from Investing

Hopeful Investors Get Scraped by the Bear

James "Rev Shark" DePorre
Jun 28, 2022 4:24 PM EDT

Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.

Bed Bath & Beyond's Weakness is Likely to Persist

Bruce Kamich
Jun 28, 2022 2:36 PM EDT

The shares have been in the single digits since early May.

Taking Another Look at ON Semiconductor's Charts

Bruce Kamich
Jun 28, 2022 1:43 PM EDT

Here's what to watch for.

Feeling Queasy Over Moderna's Outlook? Investors May Still Get Their Shot

Brad Ginesin
Jun 28, 2022 12:45 PM EDT

With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.

Penn National: Should Investors Put Their Chips Down?

Bruce Kamich
Jun 28, 2022 12:13 PM EDT

Let's check out the charts and indicators on this operator of casinos and racetracks.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login